Related Experiment Video
Updated: Jul 18, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
Preclinical models for cell cycle-targeted therapies
1Cell Division and Cancer Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.
Abstract:
Deregulation of the cell cycle machinery is frequently associated to tumor development in most cell types. Many of these tumor-associated alterations result in the abnormal activation of cyclin-dependent protein kinases (Cdks) involved in the G1/S transition. Recent results from the genetic analysis of cyclins and Cdks in mouse models have raised some questions regarding the relevance of these molecules in cell cycle-targeted strategies for cancer therapy. The comprehensive evaluation of these biochemical and genetic data seems to be a necessary given the relevance of these and other new cell cycle kinases as targets for therapeutic approaches in cancer.
Insights
Cell cycle machinery deregulation, especially cyclin-dependent protein kinases (Cdks), drives tumor development. Further evaluation of these cell cycle kinases is crucial for effective cancer therapy strategies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cell cycle deregulation is a hallmark of cancer, often involving abnormal activation of cyclin-dependent protein kinases (Cdks).
- These Cdks play a critical role in regulating the G1/S phase transition, a key checkpoint in cell proliferation.
- Recent genetic studies in mouse models have prompted re-evaluation of Cdks' therapeutic relevance.
Purpose of the Study:
- To comprehensively evaluate the role of cyclins and Cdks in cancer development.
- To assess the relevance of cell cycle kinases as therapeutic targets in oncology.
- To synthesize biochemical and genetic data for informed cancer therapy strategies.
Main Methods:
- Review and analysis of existing genetic data from mouse models.
- Evaluation of biochemical data related to cell cycle regulation.
- Comprehensive assessment of cyclin-dependent protein kinases (Cdks) and their functions.
Main Results:
- Abnormal activation of Cdks is frequently observed in tumors, contributing to uncontrolled cell division.
- Genetic analyses in mouse models have raised questions about the direct therapeutic efficacy of targeting specific Cdks.
- The precise role and therapeutic potential of Cdks require further in-depth investigation.
Conclusions:
- Understanding the complex role of cell cycle kinases, including Cdks, is essential for developing targeted cancer therapies.
- Further research is needed to validate cell cycle kinases as reliable targets for cancer treatment.
- Integrating biochemical and genetic insights is crucial for advancing cell cycle-targeted cancer strategies.
Related Concept Videos
Inhibition of Cdk Activity
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
The Cell Cycle Control System
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

